Third Arc Bio - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeThird Arc Bio
Third Arc Bio logo

Third Arc Bio

0 followers

About Third Arc Bio

Third Arc Bio is advancing antibody technology by unlocking the powerful biology of immune synapses to address solid tumors and autoimmune diseases. The company focuses on the development of multifunctional antibodies and next-generation biologics, including T cell engager programs, to treat cancer and inflammatory conditions. Based in the biotech sector, it emphasizes engineering of epitopes and antibody architectures to optimize function and target engagement across oncology and immunology indications.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Peter Lebowitz

Chief Executive Officer

Joe Erhardt

Chief Operating Officer

Sanjaya Singh

Chief Scientific Officer

Key Facts

HQ Location

Philadelphia, United States

Employees

11 - 50

Status

Private

Website

https://thirdarcbio.com